Nucleome Therapeutics raised £37.5M from M Ventures. Biotech Health services Manufacturing Pharma Investments 14 October 2022 Share:
Round value (USD): 43.51m Round investors: Merck Ventures Oxford Science Enterprises Pfizer Venture Investments JJDC - Johnson & Johnson British Patient Capital Company: Nucleome Therapeutics Industry: Biotech Health services Manufacturing Pharma
Mosaic Therapeutics closes $28m series A funding from Syncona and Cambridge Innovation Capital AI (big data) Biotech Health services Software Services Investments 02 April 2023
Prokarium in a $30M equity round led by Flerie Invest Biotech Health services Manufacturing Pharma Investments 09 February 2023
Grey Wolf Therapeutics secures $49M series B from Pfizer Venture Investments and EarlyBird VC Health services Manufacturing Pharma Investments 24 January 2023
Grey Wolf Therapeutics in a £39.6M Series B, co-led by Pfizer Venture and Earlybird Health services Manufacturing Pharma Investments 24 January 2023
Storm Therapeutics raised $30M from UTokyo Innovation Platform, Taiho Ventures, Pfizer Venture Investments, M ventures et al Biotech Health services Investments 12 December 2022